The Company capitalizes its purchases of saleable inventory of VASCEPA from suppliers that have been qualified by regulatory authorities. Inventories as of June 30, 2022 and December 31, 2021 consist of the following:


In thousands	June 30, 2022		December 31, 2021
Raw materials	$	132,687	$	107,695
Work in process		63,028		41,965
Finished goods (1)		240,309		206,270
Total inventory	$	436,024	$	355,930

(1) - During the three months ended June 30, 2022 approximately $9.6 million of finished goods were expensed through Cost of goods sold related to unsellable inventory not related to product dating.

As of June 30, 2022 and December 31, 2021, the Company had $210.3 million and $121.3 million of Long-term inventory, respectively, as consumption is expected beyond the Company's operating cycle.